PsyKey is focused on the development and commercialization of natural entheogen and nootropic based formulations, through inovative delivery systems, crafted to target and enhance bioavailability within the human systems. 
Psykey is also positioned to compliment and enter the fast evolving psycoceutical market, through the research and development of catalysts, IP, and technologies for various delivery systems, that promote optimal bioavailability and uptake of effective active ingredients. 
Founded within the terrains of life science and functional delivery systems, PsyKeys development of intellectual properties technologies are focused on not only optimal bioavailability and uptake, but the ultimate goal of increasing users neuroplasticity in order to offer the best potential experience and outcomes.